Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Index by author

01 December 2003; volume 22, issue 6

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aalbers, R.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 21 May. 2022.
  2. Agusti, C.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.
  3. Ansari, T.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  4. Assimakopoulos, T.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.
  5. Aurora, P.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 21 May. 2022.

B

  1. Balthazar, A.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.
  2. Barnes, M.C.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  3. Barnes, N.C.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  4. Barthélémy, J-C.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  5. Bernard, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  6. Bernsen, R.M.D.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 21 May. 2022.
  7. Blomberg, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  8. Blotta, M.H.S.L.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.
  9. Boehler, A.

    1. Boehler, A., and M. Estenne. "Post-transplant bronchiolitis obliterans." European Respiratory Journal 22.6 (2003): 1007-1018. Web. 21 May. 2022.
  10. Böhme, S.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  11. Boonsawat, W.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  12. Bos, A.P.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 21 May. 2022.
  13. Burns, W.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.

C

  1. Calverley, P.M.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  2. Campana, Á.O.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 21 May. 2022.
  3. Carter, E.

    1. Carter, E.. "Noseclips in children performing spirometry." European Respiratory Journal 22.6 (2003): 1046. Web. 21 May. 2022.
  4. Cavalcanti, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.
  5. Cerdá, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  6. Chavasse, R.

    1. Chavasse, R.. "From the Authors." European Respiratory Journal 22.6 (2003): 1046. Web. 21 May. 2022.
  7. Cortijo, J.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  8. Costabel, U.

    1. Costabel, U.. "Idiopathic pulmonary fibrosis: a treatable disease?." European Respiratory Journal 22.6 (2003): 872-873. Web. 21 May. 2022.
  9. Costes, F.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  10. Court-Fortune, I.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  11. Cox, G.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 21 May. 2022.
  12. Cryer, A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  13. Cseke, Z.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  14. Cullinan, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.

D

  1. Dahlem, P.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 21 May. 2022.
  2. Dave, J.R.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  3. de Jong, R.S.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 21 May. 2022.
  4. de Jongste, J.C.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 21 May. 2022.
  5. De Rose, V.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  6. Desager, K.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.
  7. Dijkgraaf, M.G.W.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 21 May. 2022.
  8. Dingli, K.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.
  9. Donaldson, G.C.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  10. Douglas, N.J.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.
  11. Dumont, X.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  12. Duverney, D.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.

E

  1. Estenne, M.

    1. Boehler, A., and M. Estenne. "Post-transplant bronchiolitis obliterans." European Respiratory Journal 22.6 (2003): 1007-1018. Web. 21 May. 2022.

F

  1. Farré, R.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.
  2. Ferrer, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.
  3. Fietze, I.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.
  4. Figg, J.K.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  5. Fischer, A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  6. Folgering, H.T.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 21 May. 2022.
  7. Fornazim, M.C.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.
  8. Forsberg, B.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  9. Fujimoto, K.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 21 May. 2022.

G

  1. Gamble, E.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  2. Garcia, C.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.
  3. Garet, M.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  4. Gaston, B.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  5. Geraldo, R.R.C.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 21 May. 2022.
  6. Gibson, G.J.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 21 May. 2022.
  7. Godoy, I.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 21 May. 2022.
  8. Gono, H.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 21 May. 2022.
  9. Groneberg, D.A.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  10. Gustafsson, P.M.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 21 May. 2022.

H

  1. Hagenbjörk-Gustafsson, A.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  2. Hamaker, M.E.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 21 May. 2022.
  3. Hamm, H.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 21 May. 2022.
  4. Hantos, Z.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.
  5. Hargreave, F.E.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 21 May. 2022.
  6. Harris, J.M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  7. Helleday, R.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  8. Hendriks, J.C.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 21 May. 2022.
  9. Heppt, W.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  10. Hom, S.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  11. Hunt, J.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.

I

  1. Ioanas, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.

J

  1. Jeffery, P.K.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  2. Jones, M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  3. Jörres, R.A.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.

K

  1. Kanniess, F.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  2. Kawakami, S.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 21 May. 2022.
  3. Kelly, M.M.

    1. Kelly, M.M., F.E. Hargreave, and G. Cox. "A method to preserve sputum for delayed examination." European Respiratory Journal 22.6 (2003): 996-1000. Web. 21 May. 2022.
  4. Kips, J.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  5. Kubo, K.

    1. Gono, H. et al "Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma." European Respiratory Journal 22.6 (2003): 965-971. Web. 21 May. 2022.
  6. Kurz, C.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 21 May. 2022.

L

  1. Léon-Velarde, F.

    1. Maggiorini, M., and F. Léon-Velarde. "High-altitude pulmonary hypertension: a pathophysiological entity to different diseases." European Respiratory Journal 22.6 (2003): 1019-1025. Web. 21 May. 2022.
  2. Lindblad, A.

    1. Gustafsson, P.M., P. Aurora, and A. Lindblad. "Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis." European Respiratory Journal 22.6 (2003): 972-979. Web. 21 May. 2022.
  3. Llombart-Bosch, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  4. Lloyd-Owen, S.J.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  5. Loddenkemper, R.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 21 May. 2022.
  6. Lorino, H.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.

M

  1. MacLeod, D.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.
  2. Maggiorini, M.

    1. Maggiorini, M., and F. Léon-Velarde. "High-altitude pulmonary hypertension: a pathophysiological entity to different diseases." European Respiratory Journal 22.6 (2003): 1019-1025. Web. 21 May. 2022.
  3. Magnussen, H.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  4. Mamoni, R.L.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.
  5. Marchal, F.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.
  6. Martinez-Losa, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  7. Mata, M.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  8. Mills, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  9. Moffat, S.A.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  10. Moon, A.M.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  11. Morcillo, E.J.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  12. Mudway, I.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  13. Müller, K-M.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 21 May. 2022.

N

  1. Newman Taylor, A.J.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  2. Ngamtrakulpanit, L.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  3. Nguyen, T-A.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  4. Nielsen-Gode, D.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  5. Nordberg, G.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.

O

  1. Olsson, H.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  2. Oostveen, E.

    1. Oostveen, E. et al "The forced oscillation technique in clinical practice: methodology, recommendations and future developments." European Respiratory Journal 22.6 (2003): 1026-1041. Web. 21 May. 2022.

P

  1. Padberg, G.W.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 21 May. 2022.
  2. Padovani, C.R.

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 21 May. 2022.
  3. Paiva, S.A.R

    1. Godoy, I. et al "Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients." European Respiratory Journal 22.6 (2003): 920-925. Web. 21 May. 2022.
  4. Pajewski, T.N.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  5. Paraskakis, E.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  6. Passam, F.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  7. Patel, I.S.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  8. Peiser, C.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  9. Penzel, T.

    1. Penzel, T.. "Is heart rate variability the simple solution to diagnose sleep apnoea?." European Respiratory Journal 22.6 (2003): 870-971. Web. 21 May. 2022.
  10. Peterson, S.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  11. Pichot, V.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  12. Prasse, A.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 21 May. 2022.
  13. Puig de la Bellacasa, J.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.

Q

  1. Quagliato, R.

    1. Fornazim, M.C. et al "Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis." European Respiratory Journal 22.6 (2003): 895-899. Web. 21 May. 2022.

R

  1. Rabe, K.F.

    1. Rabe, K.F.. "Combination therapy for chronic obstructive pulmonary disease: one size fits all?." European Respiratory Journal 22.6 (2003): 874-875. Web. 21 May. 2022.
  2. Richter, K.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  3. Roche, F.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  4. Ruíz, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.

S

  1. Santangelo, F.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  2. Seebus, E.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 21 May. 2022.
  3. Seemungal, T.A.R.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  4. Serrano-Mollar, A.

    1. Mata, M. et al "Oral N‐acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats." European Respiratory Journal 22.6 (2003): 900-905. Web. 21 May. 2022.
  5. Sforza, E.

    1. Roche, F. et al "Predicting sleep apnoea syndrome from heart period: a time-frequency wavelet analysis." European Respiratory Journal 22.6 (2003): 937-942. Web. 21 May. 2022.
  6. Siafakas, N.M.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  7. Sibille, Y.

    1. Loddenkemper, R., G.J. Gibson, and Y. Sibille. "The burden of lung disease in Europe: why a European White Book on lung disease?." European Respiratory Journal 22.6 (2003): 869-69. Web. 21 May. 2022.
  8. Smith, A.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  9. Sourvinos, G.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  10. Spandidos, D.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  11. Svensson, M.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.

T

  1. Taylor, P.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  2. Thai Dinh, Q.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  3. Thomasson, L.

    1. Blomberg, A. et al "Clara cell protein as a biomarker for ozone-induced lung injury in humans." European Respiratory Journal 22.6 (2003): 883-888. Web. 21 May. 2022.
  4. Torres, A.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.
  5. Turner, R.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  6. Tzanakis, N.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  7. Tzortzaki, E.G.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.

U

  1. Urban, P.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.

V

  1. Valencia, M.

    1. Ioanas, M. et al "Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines." European Respiratory Journal 22.6 (2003): 876-882. Web. 21 May. 2022.
  2. van Aalderen, W.M.C.

    1. Dahlem, P. et al "Incidence and short-term outcome of acute lung injury in mechanically ventilated children." European Respiratory Journal 22.6 (2003): 980-985. Web. 21 May. 2022.
  3. van der Kooi, E.L.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 21 May. 2022.
  4. van der Wouden, J.C.

    1. Bernsen, R.M.D., J.C. de Jongste, and J.C. van der Wouden. "Lower risk of atopic disorders in whole cell pertussis-vaccinated children." European Respiratory Journal 22.6 (2003): 962-964. Web. 21 May. 2022.
  5. Vaughan, J.

    1. Vaughan, J. et al "Exhaled breath condensate pH is a robust and reproducible assay of airway acidity." European Respiratory Journal 22.6 (2003): 889-894. Web. 21 May. 2022.
  6. Virchow, J.C.

    1. Prasse, A. et al "Does interferon‐γ improve pulmonary function in idiopathic pulmonary fibrosis?." European Respiratory Journal 22.6 (2003): 906-911. Web. 21 May. 2022.
  7. Vrugt, B.

    1. Seebus, E. et al "A 71‐yr-old male with increasing dyspnoea, cough and an intrathoracic mass." European Respiratory Journal 22.6 (2003): 1042-1045. Web. 21 May. 2022.

W

  1. Wedzicha, J.A.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  2. Welker, P.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  3. White, C.W.

    1. Cullinan, P. et al "Can early infection explain the sibling effect in adult atopy?." European Respiratory Journal 22.6 (2003): 956-961. Web. 21 May. 2022.
  4. Wilkinson, T.M.A.

    1. Donaldson, G.C. et al "Longitudinal changes in the nature, severity and frequency of COPD exacerbations." European Respiratory Journal 22.6 (2003): 931-936. Web. 21 May. 2022.
  5. Witt, C.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.
    2. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
  6. Wohlgemuth, M.

    1. Wohlgemuth, M. et al "Face mask spirometry and respiratory pressures in normal subjects." European Respiratory Journal 22.6 (2003): 1001-1006. Web. 21 May. 2022.
  7. Wraith, P.K.

    1. Dingli, K. et al "Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients." European Respiratory Journal 22.6 (2003): 943-950. Web. 21 May. 2022.

Z

  1. Zervou, M.

    1. Paraskakis, E. et al "Microsatellite DNA instability and loss of heterozygosity in bronchial asthma." European Respiratory Journal 22.6 (2003): 951-955. Web. 21 May. 2022.
  2. Zhong, N.

    1. Calverley, P.M. et al "Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease." European Respiratory Journal 22.6 (2003): 912-919. Web. 21 May. 2022.
  3. Zhu, J.

    1. Gamble, E. et al "Variation of CD8+ T‐lymphocytes around the bronchial internal perimeter in chronic bronchitis." European Respiratory Journal 22.6 (2003): 992-995. Web. 21 May. 2022.
  4. Zühlke, I.E.

    1. Zühlke, I.E. et al "Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD." European Respiratory Journal 22.6 (2003): 926-930. Web. 21 May. 2022.
  5. Zweng, M.

    1. Groneberg, D.A. et al "Aspirin-sensitive rhinitis-associated changes in upper airway innervation." European Respiratory Journal 22.6 (2003): 986-991. Web. 21 May. 2022.
Back to top
PreviousNext
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorials
  • Clinical Forum
  • Original Articles: Bench to Bedside: Disease Markers
  • Original Articles: Respiratory Cell Biology
  • Original Articles: Interstitial Lung Disease
  • Original Articles: COPD
  • Original Articles: Sleep-Disordered Breathing
  • Original Articles: Asthma and Atopy
  • Original Articles: Cystic Fibrosis
  • Original Articles: Mechanical Ventilation in Infants
  • Original Articles: Upper Airways
  • Original Articles: Assessment of Airways Inflammation
  • Original Articles: Valdiation of Lung Function Testing
  • Series
  • ERS Task Force
  • Case for Diagnosis
  • Correspondence
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • Pathogenesis of COVID-19 from a cell biology perspective
  • Pulsus paradoxus
  • Complications of nasal and pharyngeal swabs: a relevant challenge of the COVID-19 pandemic?
  • The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
  • The value of chest CT as a COVID-19 screening tool in children
More...

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society